National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01EF01	IBRANCE	B	Palbociclib - 125mg	125mg	Capsule	172,164,216 L.L
N04BA02	SINEMET	B	Levodopa - 250mg, Carbidopa - 25mg		Tablet, scored	1,283,690 L.L
R03AK06	SERETIDE DISKUS 250	B	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 250mcg/inhalation		Inhalation powder	2,830,132 L.L
J07AL02	PREVENAR 13	B	Polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 23F (2.2mcg)Polysaccharide for serotypes 6B (4.4mcg)Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate (0.125mg aluminium) -		Injectable suspension	6,352,343 L.L
L01EF01	IBRANCE	B	Palbociclib - 125mg	125mg	Tablet, film coated	172,164,216 L.L
M01AE11	SURGAM	B	Tiaprofenic acid - 300mg	300mg	Tablet	440,780 L.L
N02BA01	ASPIRINE	B	Acetylsalicylic acid - 300mg	0.3g	Tablet	80,631 L.L
C01EB17	PROCORALAN	B	Ivabradin (HCl) - 7.5mg	7.5mg	Tablet, film coated	1,890,786 L.L
C09BA04	BI-PRETERAX ARGININE	B	Perindopril arginine - 5mg, Indapamide - 1.25mg		Tablet, film coated	452,875 L.L
J07AL02	SYNFLORIX	B	Polysaccharide from each of 10 capsular types of pneumococcus (conjugated to carrier proteins) adsorbed onto aluminium phosphate - 1mcg/0.5ml, Polysaccharide of serotypes 41,2, 18C1,3 and 19F1,4 - 3mcg/0.5ml, 1 adsorbed onto aluminium phosphate - 0.5mg Al3+, 2 conjugated to protein D (derived from NTHi) carrier protein - ~ 13mcg, 3 conjugated to tetanos toxoid carrier protein - ~ 8mcg, 4 conjugated to diphteria toxoid carrier protein - ~ 5mcg		Injectable suspension	4,675,228 L.L
M01AE17	KETESSE	B	Dexketoprofen (trometamol) - 25mg	25mg	Tablet, film coated	399,121 L.L
N02BA51	ASPIRINE C EFFERVESCENT	B	Acetylsalicylic acid - 400mg, Vitamin C - 240mg		Tablet, effervescent	162,605 L.L
N04BA02	SINEMET	B	Levodopa - 100mg, Carbidopa - 25mg		Tablet	2,742,335 L.L
A10BD09	INCRESYNC	B	Pioglitazone - 15mg, Alogliptin - 25mg		Tablet, film coated	2,533,143 L.L
C09BA04	PRETERAX ARGININE	B	Perindopril arginine - 2.5mg, Indapamide - 0.625mg		Tablet, film coated	452,875 L.L
D07AC13	ELOCOM	B	Mometasone furoate - 1mg/g	0.1%	Lotion	282,207 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 875mg, Clavulanic Acid (potassium) - 125mg	1g	Tablet	713,561 L.L
L03AX16	MOZOBIL	B	Plerixafor - 20mg/ml	20mg/ml	Injectable solution	413,801,327 L.L
R03AK06	SERETIDE DISKUS 500	B	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 500mcg/inhalation		Inhalation powder	3,723,788 L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 1mg	1mg	Capsule, prolonged release	L.L
A10BD09	INCRESYNC	B	Pioglitazone - 30mg, Alogliptin - 25mg		Tablet, film coated	3,897,143 L.L
B01AC27	UPTRAVI	B	Selexipag - 200mcg	200mcg	Tablet, film coated	275,097,581 L.L
C09BA04	BI-PRETERAX ARGININE	B	Perindopril arginine - 10mg, Indapamide - 2.5mg		Tablet, film coated	765,990 L.L
J07AL02	PREVENAR 20	B	Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F,8, 9V,10A, 11A, 12F, 14, 15B, 18C, 19A, 19F,22F, 23F, 33F (2.2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg)Conjugated to CRM197 carrier protein (approximately 51mcg) adsorbed on aluminium phosphate (0.125mg aluminium) -		Injectable suspension	7,415,107 L.L
N02BE01	EFFERALGAN	B	Paracetamol - 500mg	500mg	Tablet, effervescent scored	129,009 L.L
R06AX29	LABIXTEN	B	Bilastine - 20mg	20mg	Tablet	584,571 L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 3mg	3mg	Capsule, prolonged release	L.L
A10BD10	KOMBIGLYZE XR	B	Saxagliptin HCl - 2.5mg, Metformin HCl - 1000mg		Tablet, extended release	4,059,748 L.L
B01AC27	UPTRAVI	B	Selexipag - 200mcg	200mcg	Tablet, film coated	613,462,617 L.L
C01EB18	RANEXA	B	Ranolazine - 375mg	375mg	Tablet, prolonged release	3,985,837 L.L

National Cancer Registry (NCR)